Pub Date : 2024-09-01Epub Date: 2024-11-06DOI: 10.1097/eus.0000000000000082
Guochen Shang, Qi He, Chaoqun Han, Xianwen Guo, Weigang Chen, Zhen Ding, Rong Lin
Background and objective: Although the impact of biliary stents on the accuracy of EUS-guided tissue acquisition (EUS-TA) is still controversial, the influence of biliary-pancreatic double stents on EUS-TA is even more inconclusive. The aim of the study was to determine whether the diagnostic yield of EUS-FNA in the diagnosis of solid pancreatic lesions will be affected after placement of biliary-pancreatic double stents.
Methods: A multicenter retrospective study including patients who underwent EUS-FNA with biliary duct obstruction was performed. Patients were divided into 2 groups according to whether there were biliary-pancreatic double stents before EUS-FNA. The patients' EUS-FNA report, histopathological results, and clinical case data were reviewed and compared.
Results: Ninety-two patients were included, 42 with biliary-pancreatic double stents and 50 without any stents. The puncture time taken by EUS-FNA was significantly longer in the stent group than the no-stent group (19 vs. 15 min, P < 0.001). No significant differences were observed in accuracy (90.5% vs. 94%), sensitivity (89.5% vs. 93.6%), specificity (100% vs. 100%), NPV (50% vs. 50%), PPV (100% vs. 100%), respectively, in both groups. Patients with larger lesions (OR = 1.600, 95% CI: 1.124-2.277) and those who required more passes had a higher diagnostic yield (OR = 9.376, 95% CI: 1.356-64.819) by multivariate analysis.
Conclusions: ERCP before EUS-FNA is feasible for the treatment of solid pancreatic lesions causing obstructive jaundice. It will not have a negative impact on the diagnostic accuracy and surgical complications, but the EUS-FNA operation time will be prolonged.
背景与目的:虽然胆道支架对eus引导下组织采集(EUS-TA)准确性的影响仍存在争议,但胆胰双支架对EUS-TA的影响更是没有定论。本研究的目的是确定放置胆胰双支架后,EUS-FNA诊断胰腺实体病变的诊断率是否会受到影响。方法:对胆管梗阻行EUS-FNA的患者进行多中心回顾性研究。根据EUS-FNA前是否有胆胰双支架,将患者分为两组。对患者的EUS-FNA报告、组织病理学结果和临床病例资料进行回顾和比较。结果:纳入92例患者,42例行双胆胰支架,50例未行双胆胰支架。支架组EUS-FNA穿刺时间明显长于无支架组(19 min vs. 15 min, P < 0.001)。两组在准确性(90.5% vs. 94%)、敏感性(89.5% vs. 93.6%)、特异性(100% vs. 100%)、NPV (50% vs. 50%)、PPV (100% vs. 100%)方面均无显著差异。多因素分析显示,病灶越大(OR = 1.600, 95% CI: 1.124-2.277)和通过次数越多的患者诊断率越高(OR = 9.376, 95% CI: 1.356-64.819)。结论:EUS-FNA前ERCP治疗梗阻性黄疸的胰腺实性病变是可行的。虽然不会对诊断准确性和手术并发症产生负面影响,但会延长EUS-FNA手术时间。
{"title":"Impact of biliary-pancreatic double stents on EUS-guided tissue acquisition among patients with solid pancreatic lesions: A multicenter study.","authors":"Guochen Shang, Qi He, Chaoqun Han, Xianwen Guo, Weigang Chen, Zhen Ding, Rong Lin","doi":"10.1097/eus.0000000000000082","DOIUrl":"10.1097/eus.0000000000000082","url":null,"abstract":"<p><strong>Background and objective: </strong>Although the impact of biliary stents on the accuracy of EUS-guided tissue acquisition (EUS-TA) is still controversial, the influence of biliary-pancreatic double stents on EUS-TA is even more inconclusive. The aim of the study was to determine whether the diagnostic yield of EUS-FNA in the diagnosis of solid pancreatic lesions will be affected after placement of biliary-pancreatic double stents.</p><p><strong>Methods: </strong>A multicenter retrospective study including patients who underwent EUS-FNA with biliary duct obstruction was performed. Patients were divided into 2 groups according to whether there were biliary-pancreatic double stents before EUS-FNA. The patients' EUS-FNA report, histopathological results, and clinical case data were reviewed and compared.</p><p><strong>Results: </strong>Ninety-two patients were included, 42 with biliary-pancreatic double stents and 50 without any stents. The puncture time taken by EUS-FNA was significantly longer in the stent group than the no-stent group (19 <i>vs.</i> 15 min, <i>P</i> < 0.001). No significant differences were observed in accuracy (90.5% <i>vs.</i> 94%), sensitivity (89.5% <i>vs.</i> 93.6%), specificity (100% <i>vs.</i> 100%), NPV (50% <i>vs.</i> 50%), PPV (100% <i>vs.</i> 100%), respectively, in both groups. Patients with larger lesions (OR = 1.600, 95% CI: 1.124-2.277) and those who required more passes had a higher diagnostic yield (OR = 9.376, 95% CI: 1.356-64.819) by multivariate analysis.</p><p><strong>Conclusions: </strong>ERCP before EUS-FNA is feasible for the treatment of solid pancreatic lesions causing obstructive jaundice. It will not have a negative impact on the diagnostic accuracy and surgical complications, but the EUS-FNA operation time will be prolonged.</p>","PeriodicalId":11577,"journal":{"name":"Endoscopic Ultrasound","volume":"13 5","pages":"287-292"},"PeriodicalIF":4.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080700/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144093186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-01Epub Date: 2024-11-08DOI: 10.1097/eus.0000000000000086
Courtney N Walker, Michael B Andrews, Douglas G Adler
Background and objectives: Sulfur hexafluoride is an inert gas that creates microbubbles to enhance diagnostic accuracy in a variety of ultrasound (US) studies and is widely used in EUS. We analyzed the reported adverse events (AEs) of the US contrast agent, sulfur hexafluoride, extensively used during EUS procedures using a US national database.
Methods: From December 2008 to January 2024, AEs reported in the Federal Drug Administration Adverse Event Reporting System database for sulfur hexafluoride were examined.
Results: There were 1069 individual reports analyzed. Reports were excluded if they contained drugs other than sulfur hexafluoride. Echocardiogram (70.9%) was the common diagnostic study in which sulfur hexafluoride was administered. The most common AE reported was anaphylactic reaction (n = 179, 16.7%), followed by hypotension (n = 162, 15.2%), cardiac arrest (n = 161, 15.1%), and dyspnea (n = 159, 14.9%). The most common gastrointestinal AE was nausea (n = 135, 12.6%). Severity of AEs ranged from nonserious to death. Death associated with sulfur hexafluoride use was reported in 58 patients (5.4% of AE reports).
Conclusions: Anaphylactic reaction was the most common AE reported with sulfur hexafluoride use, and severe AEs including death may be more common than prior large, retrospective, observational studies to date have suggested.
{"title":"Safety of the contrast enhancement agent sulfur hexafluoride in ultrasound: Analysis of the Federal Drug Administration Adverse Event Reporting System database.","authors":"Courtney N Walker, Michael B Andrews, Douglas G Adler","doi":"10.1097/eus.0000000000000086","DOIUrl":"10.1097/eus.0000000000000086","url":null,"abstract":"<p><strong>Background and objectives: </strong>Sulfur hexafluoride is an inert gas that creates microbubbles to enhance diagnostic accuracy in a variety of ultrasound (US) studies and is widely used in EUS. We analyzed the reported adverse events (AEs) of the US contrast agent, sulfur hexafluoride, extensively used during EUS procedures using a US national database.</p><p><strong>Methods: </strong>From December 2008 to January 2024, AEs reported in the Federal Drug Administration Adverse Event Reporting System database for sulfur hexafluoride were examined.</p><p><strong>Results: </strong>There were 1069 individual reports analyzed. Reports were excluded if they contained drugs other than sulfur hexafluoride. Echocardiogram (70.9%) was the common diagnostic study in which sulfur hexafluoride was administered. The most common AE reported was anaphylactic reaction (<i>n</i> = 179, 16.7%), followed by hypotension (<i>n</i> = 162, 15.2%), cardiac arrest (<i>n</i> = 161, 15.1%), and dyspnea (<i>n</i> = 159, 14.9%). The most common gastrointestinal AE was nausea (<i>n</i> = 135, 12.6%). Severity of AEs ranged from nonserious to death. Death associated with sulfur hexafluoride use was reported in 58 patients (5.4% of AE reports).</p><p><strong>Conclusions: </strong>Anaphylactic reaction was the most common AE reported with sulfur hexafluoride use, and severe AEs including death may be more common than prior large, retrospective, observational studies to date have suggested.</p>","PeriodicalId":11577,"journal":{"name":"Endoscopic Ultrasound","volume":"13 5","pages":"306-311"},"PeriodicalIF":4.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080674/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144093204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-01Epub Date: 2024-11-08DOI: 10.1097/eus.0000000000000085
Shanshan Liu, Chaoqun Han, Qi He, Guochen Shang, Yu Jin, Jun Liu, Zhen Ding, Rong Lin
Background and objectives: There are two different endoscopic ultrasonographic manifestations of gastric signet ring cell carcinoma (GSRCC). No studies have been reported on the differences in the clinical profiles of patients based on EUS examination. We aim to study the variations in clinicopathological characteristics between two distinct endoscopic ultrasonographic manifestations of GSRCC.
Methods: A total of 302 patients with GSRCC confirmed by pathological examination who underwent EUS were enrolled in the study. Based on the endoscopic ultrasonographic features, patients were categorized into two groups: type 1, where the entire layer structure disappeared, and type 2, where the layer structure was still present and appeared lymphomatoid. Clinicopathologic features were collected retrospectively and analyzed.
Results: Compared with type 2 patients, type 1 patients tended to develop GSRCC at an older age (P = 0.033) and had higher serum levels of tumor markers and were more likely to experience anemia (P < 0.001) and weight loss (P < 0.001) during the disease progression. Significant increases in the tumor size (P < 0.001), thickness of the affected gastric wall (P < 0.001), and depth of tumor invasion (P < 0.001) were observed in type 1 patients. Furthermore, type 1 patients had higher prevalence of affected blood vessels (P < 0.001), nerves (P < 0.001), lymph nodes (P < 0.001), and peritoneal metastasis (P < 0.001). However, no difference was found in the duration of disease between the two groups, and all deficient mismatch repairs were observed in type 1 patients.
Conclusions: The two distinct endoscopic ultrasonographic manifestations of GSRCC exhibited different clinicopathological characteristics, suggesting that they may represent different subtypes of the disease that require special attention in management strategies.
{"title":"The comparison of clinicopathological characteristics of two distinct manifestations of gastric signet ring cell carcinoma under EUS.","authors":"Shanshan Liu, Chaoqun Han, Qi He, Guochen Shang, Yu Jin, Jun Liu, Zhen Ding, Rong Lin","doi":"10.1097/eus.0000000000000085","DOIUrl":"10.1097/eus.0000000000000085","url":null,"abstract":"<p><strong>Background and objectives: </strong>There are two different endoscopic ultrasonographic manifestations of gastric signet ring cell carcinoma (GSRCC). No studies have been reported on the differences in the clinical profiles of patients based on EUS examination. We aim to study the variations in clinicopathological characteristics between two distinct endoscopic ultrasonographic manifestations of GSRCC.</p><p><strong>Methods: </strong>A total of 302 patients with GSRCC confirmed by pathological examination who underwent EUS were enrolled in the study. Based on the endoscopic ultrasonographic features, patients were categorized into two groups: type 1, where the entire layer structure disappeared, and type 2, where the layer structure was still present and appeared lymphomatoid. Clinicopathologic features were collected retrospectively and analyzed.</p><p><strong>Results: </strong>Compared with type 2 patients, type 1 patients tended to develop GSRCC at an older age (<i>P</i> = 0.033) and had higher serum levels of tumor markers and were more likely to experience anemia (<i>P</i> < 0.001) and weight loss (<i>P</i> < 0.001) during the disease progression. Significant increases in the tumor size (<i>P</i> < 0.001), thickness of the affected gastric wall (<i>P</i> < 0.001), and depth of tumor invasion (<i>P</i> < 0.001) were observed in type 1 patients. Furthermore, type 1 patients had higher prevalence of affected blood vessels (<i>P</i> < 0.001), nerves (<i>P</i> < 0.001), lymph nodes (<i>P</i> < 0.001), and peritoneal metastasis (<i>P</i> < 0.001). However, no difference was found in the duration of disease between the two groups, and all deficient mismatch repairs were observed in type 1 patients.</p><p><strong>Conclusions: </strong>The two distinct endoscopic ultrasonographic manifestations of GSRCC exhibited different clinicopathological characteristics, suggesting that they may represent different subtypes of the disease that require special attention in management strategies.</p>","PeriodicalId":11577,"journal":{"name":"Endoscopic Ultrasound","volume":"13 5","pages":"293-299"},"PeriodicalIF":4.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144093206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-01Epub Date: 2024-11-08DOI: 10.1097/eus.0000000000000089
Muyun Liu, Wei An, Jie Gao, Xingang Shi
{"title":"Intraductal papillary mucinous neoplasm originating from a heterotopic pancreas within the stomach.","authors":"Muyun Liu, Wei An, Jie Gao, Xingang Shi","doi":"10.1097/eus.0000000000000089","DOIUrl":"10.1097/eus.0000000000000089","url":null,"abstract":"","PeriodicalId":11577,"journal":{"name":"Endoscopic Ultrasound","volume":"13 5","pages":"317-319"},"PeriodicalIF":4.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080676/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144093189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background and objectives: According to previous reports, EUS-fine-needle biopsy (FNB) with or without rapid on-site evaluation (ROSE) showed the nonsuperiority of EUS-FNB + ROSE over EUS-FNB. However, previous studies included various kinds of FNB needle. This might be a critical limitation due to heterogeneity. Therefore, the aim of the present multicenter, randomized controlled trial was to compare the diagnostic accuracy of the fork-tip needle with or without ROSE for pancreatic lesions.
Methods: In the ROSE group, if an adequate sample was obtained to diagnose by on-site evaluation, EUS-FNB was stopped. If cytological results were insufficient or indeterminate, EUS-FNB was repeated. In the macroscopic on-site evaluation (MOSE) group, if a 4-mm length of visible core tissue was obtained, EUS-FNB was finished. If visible core tissue was not obtained or was less than 4 mm in length, a second puncture was attempted.
Results: One hundred seventy-one patients were randomized, 85 to the ROSE group and 86 to the MOSE group. In the MOSE group, diagnostic sensitivity and accuracy were 94.4% and 91.8%, respectively, for visible core tissue and 80.6% and 70.0%, respectively, for red tissue. Finally, overall diagnostic sensitivity and accuracy were 97.1% and 95.3%, respectively, in the ROSE group and 95.8% and 95.3%, respectively, in the MOSE group. Although there were no significant differences regarding adverse events between groups, the mean number of punctures was significantly lower in the MOSE group than in the ROSE group (1.47 vs. 1.20, P = 0.0171).
Conclusions: EUS-FNB using a fork-tip needle for pancreatic lesions has high diagnostic yield even without ROSE.
背景和目的:根据以往的报道,eus -细针活检(FNB)加或不加快速现场评价(ROSE)均显示EUS-FNB + ROSE优于EUS-FNB。然而,以往的研究包括各种FNB针。由于异质性,这可能是一个关键的限制。因此,本多中心随机对照试验的目的是比较带有或不带有ROSE的叉尖针对胰腺病变的诊断准确性。方法:在ROSE组中,如果获得足够的样本进行现场评价诊断,则停止EUS-FNB。如果细胞学结果不充分或不确定,则重复EUS-FNB。在宏观现场评价(MOSE)组,若获得长度为4mm的可见核心组织,则EUS-FNB完成。如果没有获得可见的核心组织或长度小于4毫米,则尝试第二次穿刺。结果:随机抽取171例患者,其中ROSE组85例,MOSE组86例。MOSE组对可见核心组织的诊断敏感性和准确率分别为94.4%和91.8%,对红色组织的诊断敏感性和准确率分别为80.6%和70.0%。最后,总的诊断敏感性和准确性在ROSE组分别为97.1%和95.3%,在MOSE组分别为95.8%和95.3%。虽然组间不良事件发生率无显著差异,但MOSE组的平均穿刺次数明显低于ROSE组(1.47 vs 1.20, P = 0.0171)。结论:叉尖针EUS-FNB对胰腺病变的诊断率高,即使没有ROSE。
{"title":"Multicenter, randomized controlled trial of EUS-guided fine-needle biopsy using a fork-tip needle with macroscopic or rapid on-site evaluation for pancreatic lesions (H<sub>2</sub>O trial).","authors":"Takeshi Ogura, Susumu Hijioka, Kazuo Hara, Nobu Nishioka, Atsushi Okuda, Saori Ueno, Hiroki Nishikawa, Masanori Yamada, Yoshikuni Nagashio, Yuya Hisada, Yumi Murashima, Kotaro Takeshita, Shin Haba, Takamichi Kuwahara, Nozomi Okuno","doi":"10.1097/eus.0000000000000087","DOIUrl":"10.1097/eus.0000000000000087","url":null,"abstract":"<p><strong>Background and objectives: </strong>According to previous reports, EUS-fine-needle biopsy (FNB) with or without rapid on-site evaluation (ROSE) showed the nonsuperiority of EUS-FNB + ROSE over EUS-FNB. However, previous studies included various kinds of FNB needle. This might be a critical limitation due to heterogeneity. Therefore, the aim of the present multicenter, randomized controlled trial was to compare the diagnostic accuracy of the fork-tip needle with or without ROSE for pancreatic lesions.</p><p><strong>Methods: </strong>In the ROSE group, if an adequate sample was obtained to diagnose by on-site evaluation, EUS-FNB was stopped. If cytological results were insufficient or indeterminate, EUS-FNB was repeated. In the macroscopic on-site evaluation (MOSE) group, if a 4-mm length of visible core tissue was obtained, EUS-FNB was finished. If visible core tissue was not obtained or was less than 4 mm in length, a second puncture was attempted.</p><p><strong>Results: </strong>One hundred seventy-one patients were randomized, 85 to the ROSE group and 86 to the MOSE group. In the MOSE group, diagnostic sensitivity and accuracy were 94.4% and 91.8%, respectively, for visible core tissue and 80.6% and 70.0%, respectively, for red tissue. Finally, overall diagnostic sensitivity and accuracy were 97.1% and 95.3%, respectively, in the ROSE group and 95.8% and 95.3%, respectively, in the MOSE group. Although there were no significant differences regarding adverse events between groups, the mean number of punctures was significantly lower in the MOSE group than in the ROSE group (1.47 <i>vs</i>. 1.20, <i>P</i> = 0.0171).</p><p><strong>Conclusions: </strong>EUS-FNB using a fork-tip needle for pancreatic lesions has high diagnostic yield even without ROSE.</p>","PeriodicalId":11577,"journal":{"name":"Endoscopic Ultrasound","volume":"13 5","pages":"300-305"},"PeriodicalIF":4.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080678/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144093200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}